Prurigo Nodularis Clinical Trials

Currently Enrolling

  • Trevi Protocol TR-11: A Phase 2B/3, randomized, double-blind, placebo-controlled, 2-Arm, efficacy and safety study in prurigo nodularis with Nalbuphine ER Tablets (an oral opioid) for pruritus relief through itch scratch modulation (PRISM Study).  |  Learn More »  |  Request to Join This Study »

 


 

View Other Clinical Trials